全文获取类型
收费全文 | 7664篇 |
免费 | 488篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 185篇 |
妇产科学 | 80篇 |
基础医学 | 883篇 |
口腔科学 | 114篇 |
临床医学 | 557篇 |
内科学 | 1756篇 |
皮肤病学 | 140篇 |
神经病学 | 444篇 |
特种医学 | 173篇 |
外国民族医学 | 1篇 |
外科学 | 1619篇 |
综合类 | 207篇 |
一般理论 | 5篇 |
预防医学 | 494篇 |
眼科学 | 153篇 |
药学 | 773篇 |
中国医学 | 150篇 |
肿瘤学 | 440篇 |
出版年
2023年 | 139篇 |
2022年 | 112篇 |
2021年 | 384篇 |
2020年 | 328篇 |
2019年 | 398篇 |
2018年 | 425篇 |
2017年 | 291篇 |
2016年 | 301篇 |
2015年 | 345篇 |
2014年 | 412篇 |
2013年 | 504篇 |
2012年 | 771篇 |
2011年 | 709篇 |
2010年 | 331篇 |
2009年 | 307篇 |
2008年 | 453篇 |
2007年 | 425篇 |
2006年 | 362篇 |
2005年 | 340篇 |
2004年 | 255篇 |
2003年 | 251篇 |
2002年 | 126篇 |
2001年 | 42篇 |
2000年 | 30篇 |
1999年 | 21篇 |
1998年 | 16篇 |
1997年 | 8篇 |
1996年 | 11篇 |
1995年 | 5篇 |
1994年 | 9篇 |
1993年 | 12篇 |
1992年 | 5篇 |
1991年 | 6篇 |
1990年 | 3篇 |
1989年 | 4篇 |
1988年 | 8篇 |
1987年 | 4篇 |
1986年 | 3篇 |
1985年 | 6篇 |
1984年 | 8篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 10篇 |
1980年 | 2篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1972年 | 3篇 |
1969年 | 3篇 |
排序方式: 共有8211条查询结果,搜索用时 15 毫秒
1.
Maria Alejandra Luna-Cuadros Hao-Wei Chen Hira Hanif Mukarram Jamat Ali Muzammil Muhammad Khan Daryl Tan-Yeung Lau Liver Center 《World journal of gastroenterology : WJG》2022,28(1):96-107
Hepatitis C virus(HCV)is a significant cause of hepatocellular carcinoma(HCC).The direct-acting antivirals marked a new era of HCV therapy and are associated with greater than 95%cure rate.Successful treatment of chronic hepatitis C greatly reduces the risk of HCC.A proportion of patients,especially those with pre-existing cirrhosis,remain at risk for HCC despite sustained virologic response(SVR).Diabetes mellitus,hepatic steatosis,alcohol consumption and lack of fibrosis regression are associated with risks of HCC after HCV cure.Noninvasive modalities such as aspartate aminotransferase to platelet ratio index and fibrosis-4 index and transient elastography have been used to monitor hepatic fibrosis.More recently,various fibrosis scores have been combined with clinical parameters and other novel biomarkers to predict risks of HCC for patients who achieved SVR.These models still need to be validated and standardized prior to applying to routine clinical care. 相似文献
2.
Farooq Muhammad Simoes Eugénio Mélanie Piquet-Pellorce Claire Dion Sarah Raguenes-Nicol Céline Santamaria Kathleen Kara-Ali Ghania Hounana Larcher Thibaut Dimanche-Boitrel Marie-Thérèse Samson Michel Le Seyec Jacques 《Journal of molecular medicine (Berlin, Germany)》2022,100(7):1027-1038
Journal of Molecular Medicine - Non-alcoholic steatohepatitis (NASH), a chronic liver disease that emerged in industrialized countries, can further progress into liver fibrosis, cirrhosis, and... 相似文献
3.
Rikke Løvendahl Eefsen Jim S. Larsen Louise L. Klarskov Rahim Altaf Estrid Høgdall Peter Ingeholm Jakob Lykke Dorte L. Nielsen Per Pfeiffer Laurids Ø. Poulsen Camilla Qvortrup Jakob V. Schou Morten Mau-Sørensen Kell Østerlind Benny V. Jensen 《International journal of cancer. Journal international du cancer》2023,152(10):2145-2152
Therapy with immune checkpoint inhibitors (ICI) is effective in patients with metastatic mismatch-repair deficient (dMMR) colorectal cancer (CRC); however, data on treatment with neoadjuvant ICI in patients with locally advanced CRC are limited. From March 2019 to June 2020, five Danish oncological centers treated 10 patients with a treatment-naïve dMMR CRC with preoperative pembrolizumab, 9 with a nonmetastatic, unresectable colon cancer and 1 with a locally advanced rectum cancer. All 10 patients were evaluated regularly at a multidisciplinary team (MDT) meeting, and they all had a radical resection after a median of 8 cycles (range 2-13) of pembrolizumab. A microscopic evaluation of the resected tumors revealed no remaining tumor cells in five patients, while five still had tumor cells present. The patients were given no additional therapy. No recurrences were reported after a median follow-up of 26 months (range 23-38.5 months). Biopsies from Danish patients with CRC are routinely screened for dMMR proteins. In 2017, data from the Danish Colorectal Cancer Group showed that 19% (565/3000) of the patients with colon cancer and 1.5% (19/1279) of those with rectum cancer had an dMMR tumor. Among the patients with MMR determination, 26% (99/384) patients had a T4 dMMR colon cancer; thus, the 10 patients treated with neoadjuvant pembrolizumab comprised about 9% of the patients with a T4 dMMR colon cancer (9/99) and 5% of patients with dMMR rectal cancer (1/19). Therapy with pembrolizumab was feasible and effective. Larger prospective trials are needed to confirm our findings. 相似文献
4.
Muhammad I. Zafar Jiequn Han Xu-Hui Zhou & Heng Xiao 《Communications In Computational Physics》2022,32(2):336-363
Partial differential equations (PDEs) play a dominant role in the mathematical modeling of many complex dynamical processes. Solving these PDEs often requires
prohibitively high computational costs, especially when multiple evaluations must be
made for different parameters or conditions. After training, neural operators can provide PDEs solutions significantly faster than traditional PDE solvers. In this work,
invariance properties and computational complexity of two neural operators are examined for transport PDE of a scalar quantity. Neural operator based on graph kernel network (GKN) operates on graph-structured data to incorporate nonlocal dependencies.
Here we propose a modified formulation of GKN to achieve frame invariance. Vector
cloud neural network (VCNN) is an alternate neural operator with embedded frame
invariance which operates on point cloud data. GKN-based neural operator demonstrates slightly better predictive performance compared to VCNN. However, GKN requires an excessively high computational cost that increases quadratically with the
increasing number of discretized objects as compared to a linear increase for VCNN. 相似文献
5.
6.
7.
Raya Saab MD Anas Obeid MD Fatiha Gachi MD Houda Boudiaf MD Lilit Sargsyan MD Khulood Al-Saad MD Tamar Javakhadze MD Azim Mehrvar MD Sawsan Sati Abbas MD Yasir Saadoon Abed Al-Agele MD Salma Al-Haddad MD Mouroge Hashim Al Ani MD Suleiman Al-Sweedan MD Amani Al Kofide MD Wasil Jastaniah MD Nisreen Khalifa MD Elie Bechara MD Malek Baassiri MD Peter Noun MD Jamila El-Houdzi MD Mohammed Khattab MD Krishna Sagar Sharma MD Yasser Wali MD Naureen Mushtaq MD Aliya Batool MD Mahwish Faizan MD Muhammad Rafie Raza MD Mohammad Najajreh MD Mohammed Awad Mohammed Abdallah MD Ghada Sousan MD Khaled M. Ghanem MD Ulker Kocak MD Tezer Kutluk MD Hacı Ahmet Demir MD Hamoud Hodeish MD Samar Muwakkit MD Asim Belgaumi MD Abdul-Hakim Al-Rawas MD Sima Jeha MD 《Cancer》2020,126(18):4235-4245
8.
Expression of Salivary S100A7 Levels in Stage I Oral Submucous Fibrosis: A Clinical and Laboratory Study 下载免费PDF全文
Muhammad Arsalan RaffatNaila Irum HadiOsama AlghamdiKhulud Abdulrahman Al-AaliModhi Al DeebTariq AbduljabbarFahim Vohra 《Asian Pacific journal of cancer prevention》2020,21(4):1115-1119
Background: Oral submucous fibrosis (OSF) is a chronic debilitating condition characterized by juxta-epithelial fibrosis. The main etiological agent associated with the high-risk precancerous condition is areca nut use. S100A7 is a member of the largest calcium-binding proteins exclusively found in vertebrates and are associated with the regulation of numerous intracellular and extracellular functions. The aim of this study was to investigate the expression of protein S100A7 in salivary samples of individuals with stage I OSF and healthy controls. Methods: This study included 63 participants, 30 of whom had OSF stage I and 33 healthy controls. Nonprobability quota sampling technique was utilized for recruitment of the study participants. A structured baseline questionnaire was used to collect demographic data. Saliva samples were collected by passive droll technique in a sterile container. Salivary levels of S100A7 were quantified by enzyme-linked immunosorbent assay. For the normality of the data Shapiro Wilk test was performed. Student t-test was commuted to evaluate the expression of S100A7 protein expression between both the study groups. Results: The mean salivary S100A7 value for stage I OSF group was 0.334 ng/ml, compared to 0.172 ng/ml for healthy controls. Student t-test reported a statistically significant difference, indicating higher levels of S100A7 in stage I OSF group than in healthy controls (p < 0.001). In the individual group analysis, a significant negative correlation was found between salivary S100A7 and duration of areca nut use (r = –0.45, p = 0.009) and gutka chewing (r = –0.20, p = 0.03), while a significant positive correlation was found between salivary S100A7 and mouth opening (r = 0.03, p = 0.04). Conclusions: Higher levels of S100A7 protein level was seen in stage I OSF group in comparison to the healthy individuals. Results of our study suggest that S100A7 could be used as a surrogate assessment to identify patients at risk of OSF development. 相似文献
9.
Dengue, a mosquito‐borne viral disease, causes about 100 million cases of infection annually. It is a major public concern, and if left untreated or improperly diagnosed, may cause serious health problems or even death. Historically, dengue has not considered priorities for pharmaceutical companies made the available treatment options. Therefore, medicinal scientists are revealing new insights and enabling novel interventions and approaches to dengue prevention and control. Diterpenes, a class of terpenes have gained much attention due to their diverse biological effects. This review aimed at summarizing available evidences of diterpenes and their derivatives acting against dengue virus and their vectors. For this, an updated search was made in the databases: PubMed and ScienceDirect by using specific keywords. Among the 117 published reports, a total of 30 articles was included in this review. Findings suggest that a number of diterpenes and/or their derivatives act against dengue virus and their two potential vectors namely Aedes aegypti and Ae. albopictus. In conclusion, diterpenes and their derivatives may have the potential alternative therapeutic tools for the management of dengue virus and some associated diseases transmitted by Aedes mosquito. 相似文献